Herpes Cure Advocacy
LightNews LightNews
herpesadvocate.bsky.social
Herpes Cure Advocacy
@herpesadvocate.bsky.social
100 followers 140 following 230 posts
We are a grassroots membership-based, international advocacy organization with a goal of treatment, cure and prevention for Herpes Simplex Virus types 1 + 2.

www.herpescureadvocacy.com
Posts Replies Media Videos
Pinned
herpesadvocate.bsky.social
Herpes Cure Advocacy @herpesadvocate.bsky.social · Jan 15
🌟 Our 2024 Annual Report is here! 🌟

Discover the milestones and impact we achieved together this past year. Thank you for being part of our journey!

herpescureadvocacy.com/2025/01/14/m...
2024 HCA Annual Report
As we reflect on the past year, we are thrilled to share our 2024 Annual Report with you. This report offers a comprehensive look at the impact we’ve achieved together, the challenges we’ve faced, …
herpescureadvocacy.com
herpesadvocate.bsky.social
Did you miss our #herpesawarenessday talk on better testing for #herpes? We have it recorded and you can find it and all our other educational talks on our website under Recorded Talks! Have a topic you're interested in learning more of? Let us know!

herpescureadvocacy.com/recorded-tal...
Recorded Talks
Herpes Cure Advocacy hosts monthly meetings covering a wide range of HSV related topics. We understand not everyone is able to attend the talks live, so we’ve created this page as a resource …
herpescureadvocacy.com
October 23, 2025 at 2:34 AM
herpesadvocate.bsky.social
More good news from AssemblyBio who expects to initiate phase 2 of ABI-5366 in mid 2026!
investor.assemblybio.com/news-release...
investor.assemblybio.com
October 12, 2025 at 7:31 PM
herpesadvocate.bsky.social
Did you know tomorrow is National #Herpes Awareness Day? In honor of it, we are hosting a talk with Dr. Camerini on the Development of Better Serological Tests for Herpes. We hope you join us!

herpescureadvocacy.com/event/develo...
Development of Better Serological Tests for HSV-1 and HSV-2 Infections with David Camerini
David Camerini is the Director of Virology at ImmPORT Therapeutics/DBA Antigen Discovery Register Here
herpescureadvocacy.com
October 12, 2025 at 7:14 PM
herpesadvocate.bsky.social
herpescureadvocacy.com/event/therap...
Therapy and prevention of long-term cognitive impairment following neonatal herpes simplex virus infections
Advancing Science is a meeting series in a partnership between Herpes Cure Advocacy and HVTN to highlight the latest science in herpes, projects that are driving the field of HSV research forward a…
herpescureadvocacy.com
October 7, 2025 at 2:46 PM
herpesadvocate.bsky.social
It’s spooky season! And we have a some great events for you this month! Next week, Dr. David Leib will give a talk on neonatal herpes! More info below:

herpescureadvocacy.com/event/therap...
Therapy and prevention of long-term cognitive impairment following neonatal herpes simplex virus infections
Advancing Science is a meeting series in a partnership between Herpes Cure Advocacy and HVTN to highlight the latest science in herpes, projects that are driving the field of HSV research forward a…
herpescureadvocacy.com
October 2, 2025 at 9:39 PM
Reposted by Herpes Cure Advocacy
junjixing.bsky.social
Herpes Simplex Virus 1-Encoded Tegument Protein VP16 Abrogates the Production of Beta Interferon (IFN) by Inhibiting NF-κB Activation and Blocking IFN Regulatory Factor 3 To Recruit Its Coactivator CBP | Journal of Virology journals.asm.org/doi/10.1128/... @asm.org @herpesadvocate.bsky.social
Herpes Simplex Virus 1-Encoded Tegument Protein VP16 Abrogates the Production of Beta Interferon (IFN) by Inhibiting NF-κB Activation and Blocking IFN Regulatory Factor 3 To Recruit Its Coactivator CBP | Journal of Virology
ABSTRACT Host cells activate innate immune signaling pathways to defend against invading pathogens. To survive within an infected host, viruses have evolved intricate strategies to counteract host immune responses. Herpesviruses, including herpes simplex ...
journals.asm.org
September 18, 2025 at 10:52 PM
herpesadvocate.bsky.social
Aicuris Announces Upcoming Oral and Poster Presentations at ID Week 2025. The company will provide an overview of the pritelivir clinical development program in two oral presentations including a comprehensive Phase 2 data overview. #herpes

www.biospace.com/press-releas...
Aicuris Announces Upcoming Oral and Poster Presentations at ID Week 2025
www.biospace.com
September 16, 2025 at 4:35 PM
herpesadvocate.bsky.social
Join us in urging CSTE to make neonatal herpes a reportable condition. Call or email CSTE leadership today — your voice can help save newborn lives and strengthen public health tracking! #Herpes #CureHSV

herpescureadvocacy.com/2025/09/11/h...
Herpes Cure Advocacy Makes Push for Neonatal Herpes as Reportable Condition
Herpes Cure Advocacy is advocating to make the neonatal herpes infection reportable via a recommendation from the CSTE. In this multiple step process to make a condition reportable, the CSTE STI co…
herpescureadvocacy.com
September 16, 2025 at 3:13 AM
herpesadvocate.bsky.social
Herpes affects millions — and still lacks a cure. Join us at #RallyMedRes to demand more NIH funding for herpes research. It’s time to be seen. #FundNIH

rallyformedicalresearch.org
Home - Rally for Medical Research
Join advocates from around the country for the 2025 Rally for Medical Research! The Hill Day will take place on Thursday, September 18, with advocates ... Read moreHome
rallyformedicalresearch.org
September 11, 2025 at 1:23 AM
herpesadvocate.bsky.social
"findings suggest that melatonin effectively protects neuronal cells against HSV-1 gD-induced oxidative stress".

With more research showing linkage between #herpes and #Alzheimer's could studies like this one further the connection?

www.sciencedirect.com/science/arti...
P18-38 Protective effects of melatonin against herpes simplex virus-1 glycoprotein D-induced oxidative stress in SH-SY5Y cells
Herpes simplex virus type 1 (HSV-1) glycoprotein D (gD) plays a critical role in viral entry and induces oxidative stress in host cells. Sleep disorde…
www.sciencedirect.com
September 10, 2025 at 3:41 AM
herpesadvocate.bsky.social
"Unexpectedly, we found that engineering antibodies into a bispecific format targeting two viral glycoproteins dramatically increased antiviral potency[...]demonstrating that delayed dosing after latency establishment can reduce disease" #herpes
www.sciencedirect.com/science/arti...
Identification and engineering of potent bispecific antibodies that protect against herpes simplex virus recurrent disease
Herpes simplex virus (HSV) causes lifelong infections, including oral and genital herpes. There is no vaccine, and current antivirals are only partial…
www.sciencedirect.com
September 10, 2025 at 3:33 AM
herpesadvocate.bsky.social
Are you signed up for our newsletter? Each month, we share the latest news, upcoming events, and ways to take action. Don’t miss out—join our mailing list to stay informed and engaged! #herpes #curehsv

herpescureadvocacy.com/members/
Become an Advocate!
Join our nearly 10,000 members rallying for a cure.
herpescureadvocacy.com
September 1, 2025 at 9:33 PM
herpesadvocate.bsky.social
We are looking for impact stories for future marketing content. If you are willing, please let us know:

🔵How have you benefitted from HCA resources (website, events, etc.)?
🔵Why do you donate to HCA? Either time if you're a volunteer or monetary donations?

#herpes #curehsv
August 31, 2025 at 6:18 PM
herpesadvocate.bsky.social
Did you know we're on YouTube? If you missed our patient/provider panel discussion from last week, you can watch the recording on Youtube or under the Recorded Talks section of our website! What other topics would you like to see HCA have? #Herpes

www.youtube.com/@herpescurea...
Herpes Cure Advocacy
A cure for Herpes Simplex Virus (HSV-1 and HSV-2) is urgently needed for the 6 billion people globally living with HSV. Herpes is not benign. We need a cure today because patients are waiting. Herpes...
www.youtube.com
August 23, 2025 at 8:44 PM
herpesadvocate.bsky.social
We’re growing our movement and need motivated people to join us! Whether you have experience in fundraising, policy work, or you’re simply passionate about driving change— your skills can help push our efforts forward. #CureHSV Learn more here:

herpescureadvocacy.com/2025/08/20/a...
Applications Open for HCA Board of Directors
Herpes Cure Advocacy Seeks Volunteer Members for Board of Directors Herpes Cure Advocacy (HCA) is issuing a call for individuals to serve on its Board of Directors. We are seeking individuals with …
herpescureadvocacy.com
August 23, 2025 at 8:35 PM
herpesadvocate.bsky.social
We had a great turnout at todays patient/provider panel! Thank you to all the participants & advocates that showed up! This is how we start bridging those gaps! If you were unable to attend, you can find the recording below under 2025 talks! #Herpes

herpescureadvocacy.com/recorded-tal...
Recorded Talks
Herpes Cure Advocacy hosts monthly meetings covering a wide range of HSV related topics. We understand not everyone is able to attend the talks live, so we’ve created this page as a resource …
herpescureadvocacy.com
August 20, 2025 at 4:16 AM
herpesadvocate.bsky.social
Today is the day! Patient/Provider discussion panel! More info below:

herpescureadvocacy.com/event/hsv-pa...
HSV Patient-Provider Panel
Join us for a powerful and honest conversation bridging the gap between healthcare professionals and the herpes patient community. This unique panel brings together leading voices in HSV education,…
herpescureadvocacy.com
August 19, 2025 at 4:13 PM
herpesadvocate.bsky.social
Great article from two of our very own board members! Advocacy can come in many forms, this is one such way that sheds light on the issue and raises awareness! #SilentNoMore #CureHSV

www.medpagetoday.com/opinion/seco...
Opinion | Why Hasn't Herpes Treatment Advanced in 40 Years?
We cannot ignore the health consequences and shame faced by people with herpes
www.medpagetoday.com
August 19, 2025 at 12:56 AM
herpesadvocate.bsky.social
Did you know Sunday's are a great time to start your advocacy efforts? Check out our advocates starter guide on ways you can get involved! We all have a voice to use! #SilentNoMore #CureHSV

herpescureadvocacy.com/2021/10/16/n...
New HSV Advocates: A Starters Guide to Activism
Getting started with Herpes Advocacy Step 1: Get Informed GET INFORMED: Make sure you know the Herpes 101 facts so you can speak to them in your advocacy. Read the latest news. Sign up for Herpes C…
herpescureadvocacy.com
August 17, 2025 at 3:28 PM
herpesadvocate.bsky.social
Nearly 100 people have registered for our upcoming patient/provider panel! Don’t miss your chance to be part of this important conversation—check out the details & sign up today. This discussion will spark the dialogue we need to move forward together. herpescureadvocacy.com/event/hsv-pa...
HSV Patient-Provider Panel
Join us for a powerful and honest conversation bridging the gap between healthcare professionals and the herpes patient community. This unique panel brings together leading voices in HSV education,…
herpescureadvocacy.com
August 17, 2025 at 1:55 AM
herpesadvocate.bsky.social
Curious what research is happening for herpes? Check out our Herpes Cure Pipeline 4.0!

herpescureadvocacy.com/2025/04/22/h...
Herpes Cure Pipeline 4.0
The Herpes Cure Pipeline 4.0 is here! Herpes Cure Pipeline 4.0Download Herpes Cure Pipeline 4.0 Release Meeting May 8, 2025 Recording The Herpes Cure Pipeline is a proprietary report produced by He…
herpescureadvocacy.com
August 11, 2025 at 1:05 AM
herpesadvocate.bsky.social
AssemblyBiosciences latest press release on their interim results for their ABI-5366 Herpes study.
✅ 94% reduction in HSV2 shedding rate
✅ 98% reduction in high viral load shedding rate,
✅ 94% reduction in genital lesion rate

This is great news for all!!

investor.assemblybio.com/news-release...
Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Study of Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366 Showing Reductions in Viral Shedding Rate and Genital Le...
The Investor Relations website contains information about Assembly Biosciences, Inc.'s business for stockholders, potential investors, and financial analysts.
investor.assemblybio.com
August 10, 2025 at 4:05 AM
herpesadvocate.bsky.social
We were thrilled to attend @stihiv2025.org in Montreal! Herpes wasn’t always center stage — but our booth, panels, and conversations made sure it had a voice. Read about our experience, what we learned, and why the fight is far from over! #SilentNoMore

herpescureadvocacy.com/2025/08/09/h...
Herpes Cure Advocacy Attends the 2025 STI & HIV World Congress
Montréal, Canada This year, members of Herpes Cure Advocacy attended the STI & HIV World Congress in Montréal, Canada — a global gathering of researchers, clinicians, public health leaders, and…
herpescureadvocacy.com
August 9, 2025 at 4:47 AM
herpesadvocate.bsky.social
We are so excited to be here at @stihiv2025.org! Stop by our booth T6 to learn more about our work to advance new therapies for HSV - and win a prize! #Herpes #CureHSV #SilentNoMore
July 28, 2025 at 4:12 PM
herpesadvocate.bsky.social
Great news from Aicuris! We look forward to seeing their next steps! #Aicuris #Herpes #CureHSV #SilentNoMore

www.aicuris.com/press-releas...
Aicuris Enrolled Last Participant in Pivotal Trial with Pritelivir to Treat Refractory Herpes Simplex Infection in Immunocompromised Patients - Aicuris
Aicuris has enrolled the final participant in their Phase 3 clinical trial of pritelivir. The study aimed to demonstrate superior efficacy and safety of priteli
www.aicuris.com
July 27, 2025 at 12:08 AM